A multicentre prospective double blinded randomised controlled trial of intravenous iron (ferric Derisomaltose (FDI)) in Iron deficient but not anaemic patients with chronic kidney disease on functional status.

Sunil BhandariV AllgarA LamplughI MacdougallP A Kalra

Published in: BMC nephrology (2021)

European Clinical Trials Database (EudraCT) No: 2014-004133-16 REC no: 14/YH/1209 Date First Registered: 2015-02-17 and date of end of trail 2015-05-23 Sponsor ref R1766 and Protocol No: IHI 141.

Keyphrases

clinical trial
iron deficiency
study protocol
randomized controlled trial
high dose
double blind
adverse drug
emergency department
wild type